MedTrace Logo

Gastrointestinal Microbiome Study of Appendiceal Cancer

NCT02599116 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-03-27

No results posted yet for this study

Summary

This study analyzes the gastrointestinal microbiome of appendiceal cancer patients with peritoneal spread scheduled to undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Participants will provide fecal samples pre- and post-operatively.

Conditions

  • Pseudomyxoma Peritonei
  • Appendiceal Neoplasm
  • Cancer, Appendiceal

Interventions

OTHER

Bio-specimen collection

Collection of bio-specimens (fecal sample) at 3 different time points One pre-operative collection, Two post-operative collections

OTHER

Questionnaire

Completion of lifestyle and food questionnaires (2) at each bio-specimen collection timepoint

Sponsors & Collaborators

Principal Investigators

  • Armando Sardi, MD · Mercy Medical Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02599116 on ClinicalTrials.gov